XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses        
Research and development $ 5,743 $ 4,242 $ 12,378 $ 9,895
General and administrative 3,540 3,729 6,764 7,081
Total operating expenses 9,283 7,971 19,142 16,976
Loss from operations (9,283) (7,971) (19,142) (16,976)
Other income/(expense), net 36 (1) 31 4
Loss before income tax benefit (9,247) (7,972) (19,111) (16,972)
Income tax benefit   588   1,089
Net loss and comprehensive loss $ (9,247) $ (7,384) $ (19,111) $ (15,883)
Net loss per share, basic $ (0.65) $ (0.50) $ (1.34) $ (1.07)
Net loss per share, diluted $ (0.65) $ (0.50) $ (1.34) $ (1.07)
Weighted Average Number of Shares Outstanding, Basic 14,265,905 14,815,731 14,299,969 14,823,348
Weighted Average Number of Shares Outstanding, Diluted 14,265,905 14,815,731 14,299,969 14,823,348